10,908
Views
89
CrossRef citations to date
0
Altmetric
Review

Streptococcus pneumoniae serotype 19A: worldwide epidemiology

, , , , &
Pages 1007-1027 | Received 20 Jul 2016, Accepted 28 Jul 2017, Published online: 28 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Bruce Cm Wang, Nathorn Chaiyakunapruk, Shuiqing Zhu, Joseph B. Babigumira, Wesley Furnback, Ramaa Chitale, Amgad Gamil, Kun Zhao & Matt Wasserman. (2022) A systematic literature review of economic evaluations of pneumococcal conjugate vaccines in east and southeast Asia (2006-2019). Expert Review of Vaccines 21:7, pages 885-898.
Read now
Lindsay R. Grant, Mary P. E. Slack, Qi Yan, Krzysztof Trzciński, Jane Barratt, Elizabeth Sobczyk, James Appleby, Alejandro Cané, Luis Jodar, Raul E. Isturiz & Bradford D. Gessner. (2021) The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy. Expert Review of Vaccines 20:6, pages 691-705.
Read now
Hye-Young Kim, Seong-Beom Park, Eun-Sil Kang, Sang-Min Lee, Hyun-Jin Kim & Matt Wasserman. (2021) Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea. Human Vaccines & Immunotherapeutics 17:3, pages 909-918.
Read now
Yara Ruiz García, Javier Nieto Guevara, Patricia Izurieta, Ivo Vojtek, Eduardo Ortega-Barría & Adriana Guzman-Holst. (2021) CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW. Expert Review of Vaccines 20:1, pages 45-57.
Read now
Germán Camacho Moreno, Luisa F. Imbachi, Aura L. Leal, Vivian M. Moreno, Jaime A. Patiño, Iván F. Gutiérrez, Sandra Beltrán, Martha I. Álvarez-Olmos, Cristina Mariño, Rocío Barrero, Fabio Espinosa, Nicolás Ramos, Liliana P. Castellar, Nella Sánchez & Anita Montañez. (2020) Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10. Human Vaccines & Immunotherapeutics 16:9, pages 2300-2306.
Read now
Myint Tin Tin Htar, Heather L. Sings, Maria Syrochkina, Bulent Taysi, Betsy Hilton, Heinz-Josef Schmitt, Bradford D. Gessner & Luis Jodar. (2019) The impact of pneumococcal conjugate vaccines on serotype 19A nasopharyngeal carriage. Expert Review of Vaccines 18:12, pages 1243-1270.
Read now
Myint Tin Tin Htar, Anita H.J. van Den Biggelaar, Heather Sings, Germano Ferreira, Margaret Moffatt, Cassandra Hall-Murray, Thomas Verstraeten, Bradford D. Gessner, Heinz-Josef Schmitt & Luis Jodar. (2019) The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review. Expert Review of Vaccines 18:10, pages 1069-1089.
Read now
Matt Wasserman, Maria Gabriela Palacios, Ana Gabriela Grajales, Michele Wilson, Cheryl McDade & Raymond Farkouh. (2019) Comment on Gomez et. al. “Response to article by Wasserman et. al. (2018) ‘Modelling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico’”. Human Vaccines & Immunotherapeutics 15:3, pages 572-574.
Read now
Matthew Wasserman, Maria Gabriela Palacios, Ana Gabriela Grajales, F. Berenice Baez/Revueltas, Michele Wilson, Cheryl McDade & Raymond Farkouh. (2019) Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico. Human Vaccines & Immunotherapeutics 15:3, pages 560-569.
Read now
Tomas Mrkvan, Stephen I. Pelton, Javier Ruiz-Guiñazú, Arto A. Palmu & Dorota Borys. (2018) Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience. Expert Review of Vaccines 17:9, pages 797-818.
Read now
Bruce A. Mungall, Javier Nieto, Lamine Soumahoro & Bernard Hoet. (2018) Letter to the editor to: Isturiz et al. Streptococcus pneumoniae serotype 19A: worldwide epidemiology. Expert review of vaccines 2017;16(10):1007-27. Expert Review of Vaccines 17:8, pages 665-668.
Read now
Matt Wasserman, Heather L Sings, Dylan Jones, Sarah Pugh, Margaret Moffatt & Raymond Farkouh. (2018) Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine. Expert Review of Vaccines 17:1, pages 71-78.
Read now

Articles from other publishers (76)

Theresa J. Ochoa, Olguita Del Águila, Isabel Reyes, Eduardo Chaparro, María E. Castillo, Francisco Campos, Andrés Saenz, Roger Hernandez, Alessandra Luna-Muschi, Franco Castillo-Tokumori, Andrea E. Montero, Brayan E. Gonzales & Erik H. Mercado. (2024) Streptococcus pneumoniae serotype 19A in hospitalized children with invasive pneumococcal disease after the introduction of conjugated vaccines in Lima, Peru. Journal of Infection and Public Health 17:1, pages 44-50.
Crossref
Yoonhang Lee, Nameun Kim, HeyongJin Roh, Diem Tho Ho, Jiyeon Park, Ju Yeop Lee, Yoon-Jae Kim, Hyo-Young Kang, Jungmin Lee, Jun-Young Song, Ahran Kim, Myoung Sug Kim, Miyoung Cho, Hye Sung Choi, Chan-Il Park & Do-Hyung Kim. (2023) Serotype distribution and antibiogram of Streptococcus parauberis isolated from fish in South Korea . Microbiology Spectrum 11:5.
Crossref
Lindsay R. Grant, Mary P.E. Slack, Christian Theilacker, Jelena Vojicic, Stéphane Dion, Ralf-Rene Reinert, Luis Jodar & Bradford D. Gessner. (2023) Distribution of serotypes causing invasive pneumococcal disease in older adults from high-income countries and impact of pediatric and adult vaccination policies. Vaccine 41:38, pages 5662-5669.
Crossref
Weronika Puzia, Jan Gawor, Robert Gromadka, Karolina Żuchniewicz, Izabela Wróbel-Pawelczyk, Patrycja Ronkiewicz, Agnieszka Gołębiewska, Waleria Hryniewicz, Ewa Sadowy & Anna Skoczyńska. (2023) Highly Resistant Serotype 19A Streptococcus pneumoniae of the GPSC1/CC320 Clone from Invasive Infections in Poland Prior to Antipneumococcal Vaccination of Children. Infectious Diseases and Therapy.
Crossref
G. G. Isaeva, L. T. Bayazitova, A. Z. Zaripova, O. F. Tupkina, T. A. Chazova, R. M. Khusainova, Yu. A. Tyurin & V. B. Ziatdinov. (2023) Regional Features of the Serotype Composition of Streptococcus pneumoniae isolated from Bacterial Carriers of Preschool Age in the Republic of Tatarstan. Epidemiology and Vaccinal Prevention 22:3, pages 26-35.
Crossref
Nienke N. Hagedoorn, Andrew Anglemyer, Charlotte Gilkison, Mica Hartley & Tony Walls. (2023) Comparison of the epidemiology of invasive pneumococcal disease between Australia and New Zealand in 2017–2021: an observational study based on surveillance data. The Lancet Regional Health - Western Pacific 36, pages 100764.
Crossref
John J Schellenberg, Heather J Adam, Melanie R Baxter, James A Karlowsky, Alyssa R Golden, Irene Martin, Walter Demczuk, Michael R Mulvey & George G Zhanel. (2023) Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011–20 . Journal of Antimicrobial Chemotherapy 78:Supplement_1, pages i37-i47.
Crossref
Weronika Puzia, Jan Gawor, Robert Gromadka, Anna Skoczyńska & Ewa Sadowy. (2023) Comparative genomic analysis of two ST320 Streptococcus pneumoniae isolates, representing serotypes 19A and 19F. BMC Genomic Data 24:1.
Crossref
Josiane Trevisol Leal, Muriel Primon-Barros, Amanda de Carvalho Robaina, Kauana Pizzutti, Mariana Preussler Mott, Danielle Silva Trentin & Cícero Armídio Gomes Dias. (2023) Streptococcus pneumoniae serotype 19A from carriers and invasive disease: virulence gene profile and pathogenicity in a Galleria mellonella model. European Journal of Clinical Microbiology & Infectious Diseases 42:4, pages 399-411.
Crossref
Leire Aguinagalde Salazar, Maurits A den Boer, Suzanne M Castenmiller, Seline A Zwarthoff, Carla de Haas, Piet C Aerts, Frank J Beurskens, Janine Schuurman, Albert JR Heck, Kok van Kessel & Suzan HM Rooijakkers. (2023) Promoting Fc-Fc interactions between anti-capsular antibodies provides strong immune protection against Streptococcus pneumoniae. eLife 12.
Crossref
Preslava M. Hristova, Hristina Y. Hitkova, Nikolay K. Balgaranov, Raina Т. Gergova & Alexandra S. Alexandrova. (2023) Pediatric case of septic arthritis due to Streptococcus pneumoniae serotype 19A. The Brazilian Journal of Infectious Diseases 27:2, pages 102742.
Crossref
Esra Ekinci, Liesbet Van Heirstraeten, Laura Willen, Stefanie Desmet, Ine Wouters, Helene Vermeulen, Christine Lammens, Herman Goossens, Pierre Van Damme, Jan Verhaegen, Philippe Beutels, Heidi Theeten & Surbhi Malhotra-Kumar. (2023) Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV. Journal of the Pediatric Infectious Diseases Society 12:1, pages 36-42.
Crossref
Matus Macaj, Lubica Perdochova & Janka Jakubikova. (2023) Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008–2019). Vaccine 41:2, pages 452-459.
Crossref
Kristen Feemster & Thomas Weiss. (2022) Letter to the Editor Regarding “Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age”. Infectious Diseases and Therapy 12:1, pages 291-294.
Crossref
Athanasia Xirogianni, Nektarios Marmaras, Theano Georgakopoulou, Anastasia Papandreou, Stelmos Simantirakis, Ioanna Magaziotou, Andreas Eliades, Vassiliki Getsi, Anastasia Anastasiou-Katsiardani, Efi Staikou, Fani Markou, Athina Argyrοpoulou, Georgia Vlachaki, Genovefa Chronopoulou, Anastasia Pangalis, Theodota Liakopoulou, Athanasios Michos, Vassiliki Spoulou, Evaggelia Lagona, George Panagiotakopoulos, Efthymia Petinaki, Elpis Mantadakis, Emmanuel Roilides, Manolis Galanakis, Vana Papaevangelou, Maria Tsolia & Georgina Tzanakaki. (2022) Pneumococcal meningitis in Greece: A retrospective serotype surveillance study in the post-PCV13 era (2010–2020). Vaccine 40:34, pages 5079-5087.
Crossref
Hiba Sabbar, Chafik Mahraoui, Magdalena Bastìas Garcià & Imane Jroundi. (2022) Streptococcus pneumoniae vaccination strategies and its expected impact on penicillin non-susceptibility in children under the age of five: Let's recap!. Vaccine: X 11, pages 100170.
Crossref
Andrew Anglemyer, Andrea McNeill, Kara DuBray, Gerard J B . Sonder & Tony Walls. (2022) Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand. Clinical Infectious Diseases 74:10, pages 1859-1861.
Crossref
Anneke Steens, Mirjam J. Knol, Wieke Freudenburg-de Graaf, Hester E. de Melker, Arie van der Ende & Nina M. van Sorge. (2022) Pathogen- and Type-Specific Changes in Invasive Bacterial Disease Epidemiology during the First Year of the COVID-19 Pandemic in The Netherlands. Microorganisms 10:5, pages 972.
Crossref
Linda Yamba Yamba, Fabian Uddén, Kurt Fuursted, Jonas Ahl, Hans-Christian Slotved & Kristian Riesbeck. (2022) Extensive/Multidrug-Resistant Pneumococci Detected in Clinical Respiratory Tract Samples in Southern Sweden Are Closely Related to International Multidrug-Resistant Lineages. Frontiers in Cellular and Infection Microbiology 12.
Crossref
R. Reyburn, E.J. Tuivaga, F.T. Ratu, E.M. Dunne, D. Nand, J. Kado, K. Jenkins, L. Tikoduadua, A. Jenney, B.P. Howden, S.A. Ballard, K. Fox, R. Devi, C. Satzke, E. Rafai, M. Kama, S. Flasche, E.K. Mulholland & F.M. Russell. (2022) The impact of 10-valent pneumococcal vaccine introduction on invasive disease in Fiji. The Lancet Regional Health - Western Pacific 20, pages 100352.
Crossref
Lifeng Li, Juanjuan Zhou, Mingchao Li, Zengyuan Yu, Kaijie Gao, Junwen Yang, Ping Cheng, Junmei Yang, Wancun Zhang, Zhidan Yu & Huiqing Sun. (2022) Comparative Genomic Analysis of Streptococcus pneumoniae Strains: Penicillin Non-susceptible Multi-drug-Resistant Serotype 19A Isolates. Current Microbiology 79:2.
Crossref
Carina Valente, Ana R. Cruz, Adriano O. Henriques & Raquel Sá-Leão. (2022) Intra-Species Interactions in Streptococcus pneumoniae Biofilms. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Jonathan Zintgraff, Paula Gagetti, Daniela Napoli, Nahuel Sanchez Eluchans, Lucia Irazu, Maria Moscoloni, Mabel Regueira, Claudia S. Lara & Alejandra Corso. (2022) Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006–2019. Temporal progression of serotypes distribution and antibiotic resistance. Vaccine 40:3, pages 459-470.
Crossref
Recep Karamert, Anıl Aktaş Tapısız & Iordanis Konstantinidis. 2022. Pediatric ENT Infections. Pediatric ENT Infections 19 27 .
Felipe P. G. Neves & Tatiana C. A. Pinto. 2022. Molecular Typing in Bacterial Infections, Volume I. Molecular Typing in Bacterial Infections, Volume I 139 152 .
Zhuoxin Liang, Jinjian Fu, Ling Li, Rongsong Yi, Shaolin Xu, Jichang Chen, Xiaohua Ye & Eric McGrath. (2021) Molecular epidemiology of Streptococcus pneumoniae isolated from pediatric community-acquired pneumonia in pre-conjugate vaccine era in Western China. Annals of Clinical Microbiology and Antimicrobials 20:1.
Crossref
Matt D. Wasserman, Johnna Perdrizet, Lindsay Grant, Kyla Hayford, Shubhra Singh, Paranjoy Saharia, Emily K. Horn & Raymond A. Farkouh. (2021) Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age. Infectious Diseases and Therapy 10:4, pages 2701-2720.
Crossref
D. W. Arends, W. R. Miellet, J. D. Langereis, T. H. A. Ederveen, C. E. van der Gaast–de Jongh, M. van Scherpenzeel, M. J. Knol, N. M. van Sorge, D. J. Lefeber, K. Trzciński, E. A. M. Sanders, H. C. Dorfmueller, H. J. Bootsma & M. I. de Jonge. (2021) Examining the Distribution and Impact of Single-Nucleotide Polymorphisms in the Capsular Locus of Streptococcus pneumoniae Serotype 19A. Infection and Immunity 89:11.
Crossref
Larisa Savrasova, Angelika Krumina, Hedija Cupeca, Indra Zeltina, Anita Villerusha, Ilze Grope, Ludmila Viksna, Elina Dimina & Sooria Balasegaram. (2021) Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018. Frontiers in Pediatrics 9.
Crossref
Samanta C. G. Almeida, Stephanie W. Lo, Paulina A. Hawkins, Rebecca A. Gladstone, Ana Paula Cassiolato, Keith P. Klugman, Robert F. Breiman, Stephen D. Bentley, Lesley McGee & Maria-Cristina de C. Brandileone. (2021) Genomic surveillance of invasive Streptococcus pneumoniae isolates in the period pre-PCV10 and post-PCV10 introduction in Brazil. Microbial Genomics 7:10.
Crossref
Ching-Fen Shen, Ju-Ling Chen, Chien-Chou Su, Wen-Liang Lin, Min-Ling Hsieh, Ching-Chun Liu & Ching-Lan Cheng. (2021) Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan. Vaccines 9:9, pages 1043.
Crossref
Laura Morelli, Luigi Lay, Darielys Santana-Mederos, Yury Valdes-Balbin, Vicente Verez Bencomo, Angela van Diepen, Cornelis H. Hokke, Fabrizio Chiodo & Federica Compostella. (2021) Glycan Array Evaluation of Synthetic Epitopes between the Capsular Polysaccharides from Streptococcus pneumoniae 19F and 19A . ACS Chemical Biology 16:9, pages 1671-1679.
Crossref
Ki Wook Yun, Kyuyol Rhie, Jin Han Kang, Kyung-Hyo Kim, Jong Gyun Ahn, Yae-Jean Kim, Byung Wook Eun, Sung Hee Oh, Hye-Kyung Cho, Young Jin Hong, Nam Hee Kim, Yun-Kyung Kim, Hyunju Lee, Taekjin Lee, Hwang Min Kim, Eun Young Cho, Chun Soo Kim, Su Eun Park, Chi Eun Oh, Dae Sun Jo, Eun Song Song, Jina Lee, Jae Hong Choi, Joon Kee Lee, Hoan Jong Lee & Eun Hwa Choi. (2021) Emergence of serotype 10A-ST11189 among pediatric invasive pneumococcal diseases, South Korea, 2014–2019. Vaccine 39:40, pages 5787-5793.
Crossref
Yan Xu, Qing Wang, Kaihu Yao, Fang Dong, Wenqi Song, Gang Liu, Baoping Xu, Wei Shi, Yue Li, Kechun Li, Yingchao Liu & Suyun Qian. (2021) Clinical characteristics and serotype distribution of invasive pneumococcal disease in pediatric patients from Beijing, China. European Journal of Clinical Microbiology & Infectious Diseases 40:9, pages 1833-1842.
Crossref
Stephane B. Dion, Maria Major, Ana Gabriela Grajales, Rajeev M. Nepal, Alejandro Cane, Bradford Gessner, Jelena Vojicic & Jose A. Suaya. (2021) Invasive pneumococcal disease in Canada 2010–2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines. Vaccine 39:22, pages 3007-3017.
Crossref
Aleksandra Polkowska, Hanna Rinta-Kokko, Maija Toropainen, Arto A. Palmu & J. Pekka Nuorti. (2021) Long-term population effects of infant 10-valent pneumococcal conjugate vaccination on pneumococcal meningitis in Finland. Vaccine 39:23, pages 3216-3224.
Crossref
Fabian Uddén, Elisabeth Rünow, Hans-Christian Slotved, Kurt Fuursted, Jonas Ahl & Kristian Riesbeck. (2021) Characterization of Streptococcus pneumoniae detected in clinical respiratory tract samples in southern Sweden 2 to 4 years after introduction of PCV13. Journal of Infection.
Crossref
Laura M.A. Oliveira, Aline R.V. Souza, Tatiana C.A. Pinto & Lucia M. Teixeira. (2021) Characterization of Streptococcus pneumoniae serotype 19F-variants occurring in Brazil uncovers a predominant lineage that can lead to misinterpretation in capsular typing. International Journal of Infectious Diseases 104, pages 580-583.
Crossref
Jose A. Suaya, Rodrigo E. Mendes, Heather L. Sings, Adriano Arguedas, Ralf-René Reinert, Luis Jodar, Raul E. Isturiz & Bradford D. Gessner. (2020) Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009‒2017. Journal of Infection 81:4, pages 557-566.
Crossref
Someswara Rao Sanapala, Bruna M. S. Seco, Ju Yuel Baek, Shahid I. Awan, Claney L. Pereira & Peter H. Seeberger. (2020) Chimeric oligosaccharide conjugate induces opsonic antibodies against Streptococcus pneumoniae serotypes 19A and 19F . Chemical Science 11:28, pages 7401-7407.
Crossref
Freya Cools, Dhoha Triki, Nele Geerts, Peter Delputte, Denis Fourches & Paul Cos. (2020) In vitro and in vivo Evaluation of in silico Predicted Pneumococcal UDPG:PP Inhibitors. Frontiers in Microbiology 11.
Crossref
Sarah Pugh, Matt Wasserman, Margaret Moffatt, Susana Marques, Juan Manuel Reyes, Victor A. Prieto, Davy Reijnders, Mark H. Rozenbaum, Juha Laine, Heidi Åhman & Raymond Farkouh. (2020) Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis. Infectious Diseases and Therapy 9:2, pages 305-324.
Crossref
Nzoyikorera Néhémie, Khalid Zerouali, Idrissa Diawara, Khalid Katfy, Fakhreddine Maaloum, Sylvestre Kabura, Bahija Zaki, Chehab Farid, Houria Belabbes & Naima Elmdaghri. (2020) Surgical wound infection caused by a multi drug resistant Streptococcus pneumoniae Serotype 19A after a total coloproctectomy with ileostomy. Pan African Medical Journal 35.
Crossref
Jaime Moreno, Carolina Duarte, Ana Paula Cassiolato, Grettel Chanto Chacón, Pedro Alarcon, Jacqueline Sánchez, Yolanda Narváez San Martín, Claudia Valenzuela, Wendy Castillo, Gabriela García Gabarrot, Samanta Cristine Grassi Almeida, Mariana López Vega, Gustavo A. Chamorro, Anibal Kawabata, Yolanda Narváez San Martín, Sara Morales, Carmen Revollo, Raquel de Bolaños, Jean Marc Gabastou, Clara Inés Agudelo & Elizabeth Castañeda. (2020) Molecular characterization of Latin American invasive Streptococcus pneumoniae serotype 19A isolates. Vaccine 38:19, pages 3524-3530.
Crossref
Malihe Masomian, Zuleeza Ahmad, Lai Ti Gew & Chit Laa Poh. (2020) Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines 8:1, pages 132.
Crossref
Saliha Kanık Yüksek, Hasan Tezer, Belgin Gülhan, Aslınur Özkaya Parlakay, Dilek Güldemir, F. Filiz Coskun-Ari, Tuğba Bedir Demirdağ, Aysun Kara Uzun, Murat Kızılgün, Sinem Solmaz, Selçuk Kılıç, Meltem Yalınay Çırak & Fatma Nur Baran Aksakal. (2020) Nasopharyngeal pneumococcal carriage in healthy Turkish children after 13-valent conjugated pneumococcal vaccine implementation in the national immunization program. Journal of Infection and Public Health 13:2, pages 266-274.
Crossref
Sara Milojević, Dušan Kekić, Ina Gajić, Vera Mijač & Nataša Opavski. (2020) Characterization of Streptococcus pneumoniae strains isolated from patients with meningitis before the introduction of pneumococcal conjugate vaccine in Serbia. Medicinski podmladak 71:2, pages 39-45.
Crossref
Huiying Chua, Shuo Feng, Joseph A. Lewnard, Sheena G. Sullivan, Christopher C. Blyth, Marc Lipsitch & Benjamin J. Cowling. (2020) The Use of Test-negative Controls to Monitor Vaccine Effectiveness. Epidemiology 31:1, pages 43-64.
Crossref
Sergey Sidorenko, Wolfgang Rennert, Yuri Lobzin, Nikolay Briko, Roman Kozlov, Leila Namazova-Baranova, Irina Tsvetkova, Vladimir Ageevets, Ekaterina Nikitina, Anastasia Ardysheva, Alina Bikmieva, Ekaterina Bolgarova, Marina Volkova, Irina Verentsova, Asiya Girina, Natalia Gordeeva, Irina Demko, Anna Dushchenko, Galina Evseeva, Ludmila Zharkova, Tatyana Yelistratova, Julia Zakharova, Natalia Ivakhnishina, Elena Zubova, Olga Kalinogorskaya, Alla Klimashina, Tatiana Kozeeva, Angelina Kraposhina, Olga Krechikova, Marina Mamaeva, Elena Nagovitsyna, Irina Protasova, Vadislav Semerikov, Natalia Sokolova, Irina Soloveva, Natalia Strelnikova, Regina Telepneva, Irina Feldblium, Galina Kholodok, Aida Chagaryan & Nadezhda Sheglinkova. (2020) Multicenter study of serotype distribution of Streptococcus pneumoniae nasopharyngeal isolates from healthy children in the Russian Federation after introduction of PCV13 into the National Vaccination Calendar. Diagnostic Microbiology and Infectious Disease 96:1, pages 114914.
Crossref
Neil Ravenscroft & Francesco Berti. 2020. Recent Trends in Carbohydrate Chemistry. Recent Trends in Carbohydrate Chemistry 239 281 .
Wojciech Malchrzak & Agnieszka Mastalerz-Migas. 2021. Medical Research and Innovation. Medical Research and Innovation 11 19 .
Jinjian Fu, Ling Li, Zhuoxin Liang, Shaolin Xu, Nan Lin, Peixu Qin, Xiaohua Ye & Eric McGrath. (2019) Etiology of acute otitis media and phenotypic-molecular characterization of Streptococcus pneumoniae isolated from children in Liuzhou, China. BMC Infectious Diseases 19:1.
Crossref
Sérgio Massora, Fernanda C. Lessa, Benild Moiane, Fabiana C. Pimenta, Hélio Mucavele, Alberto Chaúque, Anélsio Cossa, Jennifer R. Verani, Nelson Tembe, Maria da Gloria Carvalho, Carmen Muñoz-Almagro & Betuel Sigaúque. (2019) Invasive disease potential of Streptococcus pneumoniae serotypes before and after 10-valent pneumococcal conjugate vaccine introduction in a rural area, southern Mozambique. Vaccine 37:51, pages 7470-7477.
Crossref
Mukesh Kumar Yadav, Karabasappa Mailar, Jagadeesh Nagarajappa Masagalli, Sung-Won Chae, Jae-Jun Song & Won Jun Choi. (2019) Ruthenium Chloride—Induced Oxidative Cyclization of Trans-Resveratrol to (±)-ε-Viniferin and Antimicrobial and Antibiofilm Activity Against Streptococcus pneumoniae. Frontiers in Pharmacology 10.
Crossref
Felipe P.G. Neves, Nayara T. Cardoso, Claudete A.A. Cardoso, Lúcia M. Teixeira & Lee W. Riley. (2019) Direct effect of the 13-valent pneumococcal conjugate vaccine use on pneumococcal colonization among children in Brazil. Vaccine 37:36, pages 5265-5269.
Crossref
Helio S Sader, Mariana Castanheira, S J Ryan Arends, Herman Goossens & Robert K Flamm. (2019) Geographical and temporal variation in the frequency and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bacterial pneumonia: results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997–2016). Journal of Antimicrobial Chemotherapy 74:6, pages 1595-1606.
Crossref
Rodrigo Sini de Almeida, Jorge LaRotta, Mark A. Fletcher, Betsy Hilton & Alejandro Cané. (2019) Letter to streptococcus pneumoniae serotype 19A in Latin America and the Caribbean 2010–2015: A systematic review and a time series analysis. Vaccine 37:26, pages 3385-3386.
Crossref
Shabir A Madhi & David Goldblatt. (2019) The duopoly of ten-valent and 13-valent pneumococcal conjugate vaccines: do they differ?. The Lancet Infectious Diseases 19:5, pages 453-454.
Crossref
Helio S Sader, Rodrigo E Mendes, Jennifer Le, Gerald Denys, Robert K Flamm & Ronald N Jones. (2019) Antimicrobial Susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997–2016). Open Forum Infectious Diseases 6:Supplement_1, pages S14-S23.
Crossref
Tatiana Castro Abreu Pinto, Felipe Piedade Gonçalves Neves, Aline Rosa Vianna Souza, Laura Maria Andrade Oliveira, Natália Silva Costa, Luciana Fundão Souza Castro, Cláudia Rezende de Vieira Mendonça-Souza, José Mauro Peralta & Lúcia Martins Teixeira. (2019) Evolution of Penicillin Non-susceptibility Among Streptococcus pneumoniae Isolates Recovered From Asymptomatic Carriage and Invasive Disease Over 25 years in Brazil, 1990–2014. Frontiers in Microbiology 10.
Crossref
Aleksandra Polkowska, Anna Skoczyńska, Iwona Paradowska-Stankiewicz, Paweł Stefanoff, Waleria Hryniewicz, Alicja Kuch, Outi Lyytikäinen & J. Pekka Nuorti. (2019) Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland. Vaccine 37:10, pages 1365-1373.
Crossref
Lukas Richter, Daniela Schmid, Elisabeth Eva Kanitz, Ines Zwazl, Eva Pöllabauer, Joanna Jasinska, Heinz Burgmann, Michael Kundi & Ursula Wiedermann. (2019) Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program. PLOS ONE 14:1, pages e0210081.
Crossref
Godwin Oligbu, Norman K. Fry & Shamez N. Ladhani. 2019. Streptococcus pneumoniae. Streptococcus pneumoniae 215 224 .
L. Setchanova, A. Alexandrova, D. Pencheva, I. Sirakov, K. Mihova, R. Kaneva & I. Mitov. (2018) Rise of multidrug-resistant Streptococcus pneumoniae clones expressing non-vaccine serotypes among children following introduction of the 10-valent pneumococcal conjugate vaccine in Bulgaria. Journal of Global Antimicrobial Resistance 15, pages 6-11.
Crossref
Eileen M Dunne, Catherine Satzke, Felisita T Ratu, Eleanor F G Neal, Laura K Boelsen, Silivia Matanitobua, Casey L Pell, Monica L Nation, Belinda D Ortika, Rita Reyburn, Kylie Jenkins, Cattram Nguyen, Katherine Gould, Jason Hinds, Lisi Tikoduadua, Joseph Kado, Eric Rafai, Mike Kama, E Kim Mulholland & Fiona M Russell. (2018) Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys. The Lancet Global Health 6:12, pages e1375-e1385.
Crossref
Michele R. Wilson, Matt Wasserman, Taj Jadavji, Maarten Postma, Marie-Claude Breton, Francois Peloquin, Stephanie R. Earnshaw, Cheryl McDade, Heather L. Sings & Raymond Farkouh. (2018) Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada”. Infectious Diseases and Therapy 7:4, pages 539-543.
Crossref
Ana Paula Cassiolato, Samanta Cristine Grassi Almeida, Ana Lúcia Andrade, Ruth Minamisava & Maria Cristina de Cunto Brandileone. (2018) Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil. PLOS ONE 13:11, pages e0208211.
Crossref
M. Wasserman, A. Lucas, D. Jones, M. Wilson, B. Hilton, A. Vyse, H. Madhava, A. Brogan, M. Slack & R. Farkouh. (2018) Dynamic transmission modelling to address infant pneumococcal conjugate vaccine schedule modifications in the UK. Epidemiology and Infection 146:14, pages 1797-1806.
Crossref
Carlos Castañeda-Orjuela & Fernando De la Hoz-Restrepo. (2018) How cost effective is switching universal vaccination from PCV10 to PCV13? A case study from a developing country. Vaccine 36:38, pages 5766-5773.
Crossref
Michele Wilson, Matt Wasserman, Taj Jadavi, Maarten Postma, Marie-Claude Breton, Francois Peloquin, Stephanie Earnshaw, Cheryl McDade, Heather Sings & Raymond Farkouh. (2018) Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada. Infectious Diseases and Therapy 7:3, pages 353-371.
Crossref
Emmanouil I. Koutouzis, George L. Daikos, Panagiota Chatzichristou, Athanasios G. Michos, Foteini I. Koutouzi, George P. Chrousos & Vassiliki P. Syriopoulou. (2018) Characteristics of Streptococcus pneumoniae serotype 19A isolates from children in the pre and post Conjugate Vaccine Era. Single center experience 1986–2015. Vaccine 36:35, pages 5245-5250.
Crossref
Christian Theilacker, Betsy Hilton, Qin Jiang, Bradford D Gessner & Luis Jodar. (2018) Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease. Clinical Infectious Diseases 66:10, pages 1641-1642.
Crossref
Marloes Vissers, Alienke J. Wijmenga-Monsuur, Mirjam J. Knol, Paul Badoux, Marlies A. van Houten, Arie van der Ende, Elisabeth A. M. Sanders & Nynke Y. Rots. (2018) Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands. PLOS ONE 13:3, pages e0194823.
Crossref
Michelle M. Kuttel & Neil Ravenscroft. 2018. Carbohydrate-Based Vaccines: From Concept to Clinic. Carbohydrate-Based Vaccines: From Concept to Clinic 139 173 .
Ling Li, Jinjian Fu, Shunming Li, Dan Guo, Zhiyao Chen, Sidong Chen & Xiaohua Ye. (2018) Phenotypic and molecular characterization of Streptococcus pneumoniae in pre-conjugate vaccine era: A Chinese hospital-based retrospective study. Vaccine 36:5, pages 599-605.
Crossref
Ine Wouters, Liesbet Van Heirstraeten, Stefanie Desmet, Stéphanie Blaizot, Jan Verhaegen, Herman Goossens, Pierre Van Damme, Surbhi Malhotra-Kumar & Heidi Theeten. (2018) Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme. Vaccine 36:1, pages 15-22.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.